论文部分内容阅读
肝肾囊肿的治疗中以介入治疗为主要手段,目前临床上使用的硬化剂多为无水乙醇[1-2]。但使用无水乙醇作为硬化剂存有不良反应,且具有潜在肝肾损害等缺陷,限制了其在临床上的运用[3]。聚桂醇是一种新型的介入治疗硬化剂,研究其在介入治疗中的效果,具有重要意义。1资料与方法1.1一般资料选取2012-01/2014-01月接受肝肾囊肿介入治疗患者102例,共117个囊肿。依据患者意愿自行选择
The treatment of liver and kidney cysts as the main means of interventional treatment, the current clinical use of mostly hardener ethanol [1-2]. But the use of anhydrous ethanol as a hardener adverse reactions, and has potential defects such as liver and kidney damage, limiting its clinical use [3]. Lauryl alcohol is a new type of interventional therapy sclerosing agent, and its effect in interventional therapy is of great significance. 1 Materials and Methods 1.1 General Information Selected 2012 - 01 / 2014-01 months received interventional treatment of liver and kidney cysts in 102 patients, a total of 117 cysts. Choose according to the patient’s wishes